Van Strydonck, Gerald E. 4
4 · VACCINEX, INC. · Filed Apr 2, 2019
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Van Strydonck, Gerald E.
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-03-31+2,501→ 2,501 totalExercise: $5.26Exp: 2029-03-30→ Common Stock (2,501 underlying)
Holdings
- 4,500
Stock Option (Right to Buy)
Exercise: $10.00Exp: 2020-03-06→ Common Stock (4,500 underlying) - 7,500
Stock Option (Right to Buy)
Exercise: $14.90Exp: 2023-03-06→ Common Stock (7,500 underlying) - 6,396
Stock Option (Right to Buy)
Exercise: $13.60Exp: 2027-09-15→ Common Stock (6,396 underlying)
Footnotes (2)
- [F1]Exercisable in full as of the date of this report.
- [F2]Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable.